Autoimmune-mediated congenital heart block

被引:42
|
作者
Wainwright, Benjamin [1 ]
Bhan, Rohit [1 ]
Trad, Catherine [1 ]
Cohen, Rebecca [1 ]
Saxena, Amit [1 ]
Buyon, Jill [1 ]
Izmirly, Peter [1 ]
机构
[1] NYU, Sch Med, New York, NY USA
关键词
Congenital heart block; Anti-SSA/Ro autoantibodies; Neonatal lupus; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIAC NEONATAL LUPUS; ANTI-RO/SSA ANTIBODIES; AMINO-ACID; 200-239; CUTANEOUS MANIFESTATIONS; MATERNAL AUTOANTIBODIES; FLUORINATED STEROIDS; SSB/LA ANTIBODIES; RECURRENCE RATES; INFANTS BORN;
D O I
10.1016/j.bpobgyn.2019.09.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Autoimmune-mediated congenital heart block (CHB) is a severe manifestation of neonatal lupus in which conduction tissues of the fetal heart are damaged. This occurs due to passive transference of maternal anti-SSA/Ro and anti-SSB/La autoantibodies and subsequent inflammation and fibrosis of the atrioventricular (AV) node. Notably, the disease manifests after the fetal heart has structurally developed, ruling out other anatomical abnormalities that could otherwise contribute to the block of conduction. Complete AV block is irreversible and the most common manifestation of CHB, although other cardiac complications such as endocardial fibroelastosis (EFE), dilated cardiomyopathy, and valvular insufficiency have been observed. In this review, we detail the classification, prevalence, pathogenesis, and clinical management recommendations for autoimmune CHB. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 50 条
  • [1] Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block
    Suryawanshi, Hemant
    Clancy, Robert
    Morozov, Pavel
    Halushka, Marc K.
    Buyon, Jill P.
    Tuschl, Thomas
    CARDIOVASCULAR RESEARCH, 2020, 116 (08) : 1446 - 1457
  • [2] Prevention and Treatment In Utero of Autoimmune-Associated Congenital Heart Block
    Saxena, Amit
    Izmirly, Peter M.
    Mendez, Barbara
    Buyon, Jill P.
    Friedman, Deborah M.
    CARDIOLOGY IN REVIEW, 2014, 22 (06) : 263 - 267
  • [3] Interferons and innate immune activation in autoimmune congenital heart block
    Ambrosi, Aurelie
    Thorlacius, Gudny Ella
    Sonesson, Sven-Erik
    Wahren-Herlenius, Marie
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (01)
  • [4] Autoimmune congenital heart block: complex and unusual situations
    Brito-Zeron, P.
    Izmirly, P. M.
    Ramos-Casals, M.
    Buyon, J. P.
    Khamashta, M. A.
    LUPUS, 2016, 25 (02) : 116 - 128
  • [5] Molecular mechanisms of congenital heart block
    Ambrosi, Aurelie
    Sonesson, Sven-Erik
    Wahren-Herlenius, Marie
    EXPERIMENTAL CELL RESEARCH, 2014, 325 (01) : 2 - 9
  • [6] The clinical spectrum of autoimmune congenital heart block
    Brito-Zeron, Pilar
    Izmirly, Peter M.
    Ramos-Casals, Manuel
    Buyon, Jill P.
    Khamashta, Munther A.
    NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (05) : 301 - 312
  • [7] Neonatal congenital heart block
    Yildirim, Ayse
    Tunaodlu, F. Sedef
    Karaadac, Aysu Turkmen
    INDIAN PEDIATRICS, 2013, 50 (05) : 483 - 488
  • [8] Autoimmune Congenital Complete Heart Block: How Late Can It Occur?
    Makadia, Luv
    Izmirly, Peter
    Buyon, Jill P.
    Phoon, Colin K. L.
    AJP REPORTS, 2023, 13 (02): : E29 - E34
  • [9] Autoimmune-mediated renal disease and
    Boesen, Erika I.
    Kakalij, Rahul M.
    CLINICAL SCIENCE, 2021, 135 (17) : 2165 - 2196
  • [10] Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report
    Zhao, Li
    Zhou, Yan
    Wang, Chuan
    Li, Yifei
    Zhu, Qi
    Hua, Yimin
    Qiao, Lina
    Wu, Jinlin
    Zhou, Kaiyu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8